This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-003472-ml4pbewf | Why should it be so? |
| cord-002724-gtv9syzi | Immunodepression following neurosurgical procedures Depression of the mononuclear phagocyte system caused by high doses of narcotics Granulocytemacrophage colony- stimulating factor( GM- CSF) restores decreased monocyte HLA- DR expression after cardiopulmonary bypass Delayed recovery of human leukocyte antigen- DR expression after cardiac surgery with early non- lethal postoperative complications: only an epiphenomenon? |
| cord-004395-erqmbi2b | Vaccine design for H5N1 based on B- and T- cell epitope predictions Methods for prediction of peptide binding to MHC molecules: a comparative study Induction of broad cross- subtype- specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques First- in- human randomized controlled trial of mosaic HIV-1 Immunogens delivered via a modified Vaccinia Ankara vector Analysis of the history and spread of HIV-1 in Uganda using phylodynamics Mapping HLA- A2, −A3 and-B7 supertype- restricted T- cell epitopes in the ebolavirus proteome Enhancing in silico protein- based vaccine discovery for eukaryotic pathogens using predicted peptide- MHC binding and peptide conservation scores Discovering a vaccine against neosporosis using computers: is it feasible? |
| cord-002463-qhtj1pef | : what should be done to combat the epidemic in 2014? |
| cord-009323-sfxpchma | Polymerase chain reaction to evaluate ant3viral therapy for cytomegalovirus disease Autologous peripheral stem ceU transplantation in children Grafi- versus- host disease Bone marrow transplantation Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantafion: Where do we stand? |
| cord-007664-c5snhymz | Does T cell restriction to Ia limit the need for self- tolerance? |
| cord-003143-n6b0r92e | Two years after pandemic influenza A/2009/ H1N1: what have we learned? |
| cord-009571-mygj2nd4 | Activation? |
| cord-007301-5m269nzi | Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three- dimensional problem? |
| cord-016998-6n662amh | : ▬ Wo liegt die wahre Motivation der Spende? |
| cord-288916-i8ukefp8 | If IFITM1/3 are'pro- oncogenic', why would cervical cancer panels reveal an inverse correlation between IFITM1/3 expression and cancer- positive lymph nodes in patients? |
| cord-005480-yg7salqt | What to do when the first allogeneic stem cell transplantation fails? |
| cord-005480-yg7salqt | Why is important to built a paediatric nurse group inside PDs WP? |
| cord-280172-6o1gqe8v | How good is automated protein docking? |
| cord-289711-4ab3d00h | Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non- human Primates Molecular Mechanism for Antibody- Dependent Enhancement of Coronavirus Entry Is COVID-19 receiving ADE from other coronaviruses? |
| cord-005478-5iu38pr6 | These results warrant prospective comparative trials of PTCy versus standard use of ATG- based GVHD Disease status: CR1 Disclosure: Nothing to declare O178 Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? |
| cord-005478-5iu38pr6 | https://www.clinicaltrials.gov/ct2/show/NCT01560182? |
| cord-310252-0cdqhrcw | The role of IFN- alpha as homeostatic agent in the inflammatory response: A balance between danger and response? |
| cord-126015-zc7u3g34 | Donor- Recipient Pairs Killer Immunoglobulin- Like Receptor- Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations Stem cell transplantation as a dynamical system: are clinical outcomes deterministic? |
| cord-126015-zc7u3g34 | The narrowing of the CD8 T cell repertoire in old age Diversity and clonal selection in the human T- cell repertoire Mechanisms shaping the naïve T cell repertoire in the elderly-thymic involution or peripheral homeostatic proliferation? |
| cord-002704-cpa2sl50 | Why prevent, diagnose and treat congenital toxoplasmosis? |
| cord-002704-cpa2sl50 | how good are HLA transgenic mice as a model of human immune responses? |
| cord-306308-zjq6cscm | what we know so far COVID-19, SARS and MERS: are they closely related? |
| cord-254190-bxfne94u | the complex pathobiology of HIV- associated neurocognitive disorders? |
| cord-254190-bxfne94u | vaccines Humanized mice: are we there yet? |
| cord-316330-55nd3pwe | is a receptor for severe acute respiratory syndrome 7 pH- dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC- SIGN ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin- converting enzyme 2 gene: lack of association with SARS in the Vietnamese population Immunity to viruses Role of early cytokines, including alpha and beta interferons( IFN- alpha/ beta), in innate and adaptive immune responses to viral infections Immunogenetics of viral infections HLA and infectious diseases Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? |
| cord-013093-aa4cf44u | Defining HLA- II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction Is It Possible to Develop a"Universal"Influenza Virus Vaccine? |
| cord-013093-aa4cf44u | Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination Is It Possible to Develop a"Universal"Influenza Virus Vaccine? |
| cord-326554-iphe3rni | AllergenFP: allergenicity prediction by descriptor fingerprints Is there an immune deficit in Whipple's disease? |
| cord-320490-3jmo35jc | Do salt bridges stabilize proteins? |
| cord-347647-m9vk9m7h | allogeneic stem cell cryopreservation been given the'cold shoulder'? |
| cord-031937-qhlatg84 | Clostridium difficile: an under- recognized cause of reactive arthritis? |
| cord-031937-qhlatg84 | how do classical and non- classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? |
| cord-275608-joyan7ij | Why must T cells be cross- reactive? |
| cord-275608-joyan7ij | Why must T cells be cross- reactive? |
| cord-298169-2133gahl | Faster? |
| cord-298169-2133gahl | The HLA 8.1 ancestral haplotype in schizophrenia: dual implication in neuro- synaptic pruning and autoimmunity? |
| cord-280641-zqdrzyzl | Por qué, entonces, no se ha encontrado un agente causal? |
| cord-280641-zqdrzyzl | results by race and sex of the ACCESS study Is there a role for microorganisms in the pathogenesis of sarcoidosis? |
| cord-103662-a4ok5wqc | Are Associated with a Decreased Risk of Progression to AIDS- Related Complex or AIDS Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control Preferential CTL targeting of Gag is associated with relative viral control in long- term surviving HIV-1 infected former plasma donors from China Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 Cell- mediated anti- Gag immunity in pharmacologically induced functional cure of simian AIDS: a'bottleneck effect'? |
| cord-103662-a4ok5wqc | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-342942-1s32o9m8 | SARS- CoV-2 infection- induced immune responses: friends or foes? |
| cord-333391-6l0cpvgr | : What might we learn from natural sequence variants? |
| cord-271032-imc6woht | COVID-19: a double- edged sword? |
| cord-271032-imc6woht | Fighting on the Front 1761 Lines or Fanning the Flames of COVID-19? |
| cord-271032-imc6woht | Should we stimulate or suppress immune responses in COVID-19? 1663 Cytokine and anti- cytokine interventions Gene List to a Gene Regulatory Network Using Large Motif and Track Collections Heterogeneity among septic shock patients in a 1670 set of immunoregulatory markers Human suppressive neutrophils |
| cord-348283-7xorq5ce | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-348283-7xorq5ce | Does urbanization make emergence of zoonosis more likely? |
| cord-018714-i291z2ju | How is HHV-6 acquired? |
| cord-018714-i291z2ju | What are the targets of cell- mediated cytotoxicity? |
| cord-018714-i291z2ju | a brief report In vitro interferon- gamma release test in the diagnosis of druginduced erythema nodosum Drug induced psoriasis Advances in the diagnosis of drug eruptions Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? |
| cord-334603-yt2pmxi3 | ( CLEC4 M) plays a protective role in SARS coronavirus infection Black/ white differences in leukocyte subpopulations in men HLA studies in the context of coronavirus outbreaks Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-334603-yt2pmxi3 | Is ethnicity linked to incidence or outcomes of covid-19? Association of HLA class I with severe acute respiratory syndrome coronavirus infection Association of human- leukocyteantigen class |
| cord-017702-v46ye328 | Should we use N- acetyltransferase type 2 genotyping to personalize isoniazid doses? |
| cord-017702-v46ye328 | can genetics help guide treatment? |
| cord-017702-v46ye328 | can pharmacogenomics improve malaria drug policy? |
| cord-015389-vwgai4k9 | C allow a long- term hematopoietic reconstitution and clinical course even if storage is greater than 6 months? |
| cord-015389-vwgai4k9 | Can type of delivery infl uence cord blood units'quality? |
| cord-015389-vwgai4k9 | The disease free survival in this small cohort of high risk patients with t- FL is encouraging but needs longer follow- up Rituximab or not? |
| cord-273906-s7l0yxc0 | : How do classical and non- classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? |
| cord-273906-s7l0yxc0 | Does this mean that the S protein might function as a double- edged sword- that is, being crucial for viral entry into the host cell, but also important for overstimulating the immune responses, causing severe inflammation that aids the spread of the virus to surrounding cells? |
| cord-273906-s7l0yxc0 | The RCSB Protein Data Bank: New resources for research and education Rosetta FlexPepDock web server- High resolution modeling of peptide- protein interactions Deciphering the structural effects of activating EGFR somatic mutations with molecular dynamics simulation Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB Comparison of simple potential functions for simulating liquid water Visual Molecular Dynamics Software for processing and analysis of molecular dynamics trajectory data UCSF Chimera- A visualization system for exploratory research and analysis Friends or foes? |
| cord-352150-ey9kc7zj | A very high level of crossreactivity is an essential feature of the T- cell receptor Why must T cells be cross- reactive? |
| cord-352150-ey9kc7zj | its orientation in the TCR- MHC complex T cell antigen receptor recognition of antigen- presenting molecules Reconciling views on T cell receptor germline bias for MHC A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product T cell receptor reversed polarity recognition of a self- antigen major histocompatibility complex Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? |
| cord-275677-hbv49e01 | : are we there yet? |
| cord-275677-hbv49e01 | AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co- receptor Molecular biology of cancer- associated fibroblasts: can these cells be targeted in anti- cancer therapy? |
| cord-275677-hbv49e01 | An example is the emergence and selection of HIV subtype C virus in India, which contains multiple NF- kB( sites?) and strengthens the promoters of the virus. |
| cord-313474-1gux1gsi | ( n ¼ 1 Introduction: Our previous research has provided the evidence that an autoreactive immune system can be? |
| cord-313474-1gux1gsi | ( range) Time to Minimum On- tx( days) Proportion? |
| cord-313474-1gux1gsi | reset? |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-355374-e8k72955 | Can we rationally design vaccines to specifically evoke Trm? |
| cord-355374-e8k72955 | So, what do we currently know about the factors that drive Trm? |
| cord-355374-e8k72955 | Why do Trm provide superior protection against influenza virus infection? |
| cord-018595-x3tleomb | Pseudoporphyria induced by voriconazole Pseudoporphyria induced by propionic acid derivatives Diclofenac- induced pseudoporphyria; an under- recognized condition? |
| cord-018595-x3tleomb | Results from the prospective RegiSCAR study Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? |
| cord-018595-x3tleomb | Variability in the clinical pattern of cutaneous side- effects of drugs with systemic symptoms: does a DRESS syndrome really exist? |
| cord-018595-x3tleomb | What is a serious adverse event? |
| cord-346445-hgqohdct | Could the D614 G substitution in the SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-346445-hgqohdct | Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-346445-hgqohdct | higher case fatality rate Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-349451-vak2p7ac | Imminent Threat or Protective Effect? |
| cord-349451-vak2p7ac | Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak-United States Helminths in the hygiene hypothesis: sooner or later? |
| cord-349451-vak2p7ac | Vaccine against autoimmune disease: can helminths or their products provide a therapy? |
| cord-017856-4fccnygg | Clinicopathologic correlations during the first 6 months after lung transplantation Interpretation of transbronchial lung biopsies from lung transplant recipients: inter- and intraobserver agreement Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation Can immunohistological analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts? |
| cord-017856-4fccnygg | Mismatches at the HLA- dr and HLA- b loci are risk factors for acute rejection after lung transplantation Does human leukocyte antigen matching influence the outcome of lung transplantation? |
| cord-017856-4fccnygg | The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart- lung transplant report-2013; focus theme: age Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? |
| cord-017856-4fccnygg | cellular and humoral processes Severity of lymphocytic bronchiolitis predicts long- term outcome after lung transplantation Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? |
| cord-017856-4fccnygg | do the benefits outweigh the risks? |
| cord-005460-ezrn8cva | Any role of high- dose chemotherapy in mediastinal nonseminoma germ cell tumors? |
| cord-005460-ezrn8cva | Gut microbiota and hematopoietic stem cell transplantation: where do we stand? |
| cord-005460-ezrn8cva | Is it feasible? |
| cord-005460-ezrn8cva | To wash or not to wash? |
| cord-266204-ipa017wz | * 03-bound measles virus peptides by 2D- liquid chromatography tandem mass spectrometry Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T- cell and B- cell epitopes?: |
| cord-266204-ipa017wz | : how much can the adaptive immune system adapt? |
| cord-266204-ipa017wz | Is science leading us toward a new path of directed vaccine development and discovery? |
| cord-266204-ipa017wz | The immunogenetics of smallpox vaccination Genetic basis for adverse events after smallpox vaccination Identification of fever and vaccine- associated gene interaction networks using ontology- based literature mining Common variants associated with general and MMR vaccine- related febrile seizures The clinician's guide to the anti- vaccinationists'galaxy Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti- vaccine and consumer culture and vaccinomics Understanding those who do not understand: a brief review of the anti- vaccine movement Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics Cell culture- based influenza vaccines: A necessary and indispensable investment for the future Ebola virus vaccines: where do we stand? |
| cord-266204-ipa017wz | We have asked the question, as have other scientists,''does it make sense in the 21st century to give the same vaccine, dose, and at the same frequency to everyone, regardless of age, weight, gender, race, genotype, and medical condition?" |
| cord-014976-546zaoxn | Are peak level measurements of cyclosporin A useful in allogeneic stem cell transplantation? |
| cord-014976-546zaoxn | How much change in quantitative chimerism values is enough for clinical significance? |
| cord-014976-546zaoxn | The case raises a number of important questions regarding the biological implications of chimerism values, such as: 1) is 10% a relative or absolute figure; 2) is there a minimum/ threshold chimerism value for functionality of the graft in these metabolic diseases; 3) do all patients have the same% chimerism interval/ differential and threshold? |
| cord-014976-546zaoxn | Why will an amotosalen- based protocol for extracorporeal photopheresis be valuable? |
| cord-014976-546zaoxn | how to learn from artefacts? |
| cord-017184-1ewi3dka | Il bambino con deficit di IgA: le caratteristiche cliniche, immunologiche e genetiche per una corretta gestione Il bambino immunodepresso Th1 T- cell and monocyte defects Autoimmune lymphoproliferative syndrome( ALPS) in a child from consanguineous parents: a dominant or recessive disease? |
| cord-017184-1ewi3dka | Long- term followup and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation? |
| cord-017184-1ewi3dka | Phenotypic and functional characteristics of peripheral B lymphocytes Localization of the properdin structural locus to Xp11.23-Xp21 Cellular and cytokine abnormalities in common variable immunodeficiency Hypoparathyroidism and the DiGeorge syndrome Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow- up study in a single centre Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? |
| cord-017184-1ewi3dka | Wiskott- Aldrich syndrome? |
| cord-017184-1ewi3dka | prospective data from the United Kingdom Children's Cancer Study Group Registry Lowered yields of virus- induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children Clinical heterogeneity and reversibility of selective immunoglobulin A deficiency in 80 children Two siblings with deficiency of IgA1, IgG2, IgG4 and IgE due to deletion of immunoglobulin heavy chain constant region genes Extensive deletion of immunoglobulin heavy chain constant region genes in the absence of recurrent infections: when is IgG subclass deficiency clinically relevant? |
| cord-287709-y247lan1 | EC/2006 for setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells Human Tissue Authority Obtaining an accepted investigational new drug application to operate an umbilical cord blood bank FDA guidance for industry and FDA staff investigational new drug applications( INDs) for minimally manipulated, unrelated allogeneic placental/ umbilical cord blood intended for hematopoietic reconstitution for specified indications Probability of finding HLA mismatched related or unrelated marrow or cord blood donors Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? |
| cord-287709-y247lan1 | The need for new donor options Introduction of mini consent process for the collection of cord blood following implementation of EU Directive 2004/23/ EC Comparison between two strategies for umbilical cord blood collection In utero or ex utero cord blood collection: which is better? |
| cord-287709-y247lan1 | a pilot study of autologous cord blood infusion in children with acquired neurologic disorders Cord blood banking in London: the first 1000 collections Does ethnicity affect cell dose in cord blood donation? |
| cord-287709-y247lan1 | the selection and acquisition of unrelated cord blood grafts Human UC- blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34+ cell recovery Factors associated with parameters of engraftment potential of umbilical cord blood Initial cord blood unit volume affects mononuclear cell and CD34+ cell- processing efficiency in a non- linear fashion Evaluation of volume and total nucleated cell count as cord blood selection parameters Factors affecting umbilical cord blood stem cell suitability for transplantation in an in utero collection program Optimizing donor selection for public cord blood banking: influence of maternal, infant and collection characteristics on cord blood unit quality Review of factors influencing the banking of collected umbilical cord blood units Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative? |
| cord-009836-7o6htufh | -the war being lost What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? |
| cord-009836-7o6htufh | : how important are they in viral evasion of immune clearance in vivo? |
| cord-009836-7o6htufh | Chisari FV Hepatitis B virus( HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection Chisari FV Is antigenic variability a strategy adopted by hepatitits B virus to escape cytotoxic T- lymphocyte surveillance? |
| cord-009836-7o6htufh | This patient clearly bad the capacity to make CTL responses to a broad range of epitopes in HIV; why then was his initial response so highly foctised on a single epitope? |
| cord-009836-7o6htufh | Why ca n't cytotoxic T cells handle HIV? |
| cord-009836-7o6htufh | as the host immune response is aiso adaptive, can it in turn evoive in response to the emergence of escape viral variants? |
| cord-319993-er3sm4u8 | A listeria- based vaccine that secretes the sand fly salivary protein LJM11 confers long- term protection against vector- transmitted Leishmania major Sand- Fly Saliva- Leishmania- Man: the trigger trio Tick salivary compounds: their role in modulation of host defences and pathogen transmission Making vaccines"on demand": a potential solution for emerging pathogens and biodefense? |
| cord-319993-er3sm4u8 | A travel guide to Cytoscape plugins Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection T cell epitope: Friend or Foe? |
| cord-319993-er3sm4u8 | Due to their commensal nature and need to avoid human immune responses over many years of coexistence, it is even NTD/ EID: time for T? |
| cord-319993-er3sm4u8 | Has the microbiota played a critical role in the evolution of the adaptive immune system? |
| cord-319993-er3sm4u8 | key: cord-319993-er3sm4u8 authors: Terry, Frances E; Moise, Leonard; Martin, Rebecca F; Torres, Melissa; Pilotte, Nils; Williams, Steven A; De Groot, Anne S title: Time for T? |
| cord-009567-osstpum6 | ( for women) and"How difficult is it for you to get or keep an erection?" |
| cord-009567-osstpum6 | : Can We Afford It? |
| cord-009567-osstpum6 | :"How difficult is it for your vagina to get or stay wet or moist?" |
| cord-009567-osstpum6 | Roberto Hernandez- Alejandro, 1 Xusheng Zhang, 2 Dong Chen, 2 Xiufen Zheng, 2 Hongtao Sun, 2 Weihua Liu, 2 Marianne Beduhn, 2 Aminah Shunnar, 2 Motohiko Suzuki, 2 Norihiko Kubo, 2 Bertha Garcia, 2 Anthony Jevnikar, 1,2 Living kidney donation is rapidly increasing worldwide to offer a partial(?) solution for the numerous ESRD wait- listed pts. |
| cord-009567-osstpum6 | These include the phosphorylation of PERK target eIF2? |
| cord-009567-osstpum6 | or Not Enough? |
| cord-022888-dnsdg04n | /CRTAM on gd T cells? |
| cord-022888-dnsdg04n | As the results show, could there not be a direct relationship between the HLA system and the development of SA or TBC, or in contrast, was the first patient missdiagnosed of TBC being a good prognosis SA? |
| cord-022888-dnsdg04n | Could Carabin play a role of negative regulator of B cell function? |
| cord-022888-dnsdg04n | How is the IGSF4-CRTAM axis regulated in T cells? |
| cord-022888-dnsdg04n | a one- year prospective birth cohort study PC09/16 TO WHAT EXTENT T- SPOT.TB COULD BE USED IN THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN EXPOSED TO TB INFECTION? |
| cord-286858-zbhtl2yn | Why does the repeated game it plays- Covid game- have long and branching chains, intertwined hierarchies, plenty of room for deception, and explosive growth rates? cord-286858-zbhtl2yn Can it reach an NE( Nash equilibria), in which self separates from non- self, decoy epitopes from neutralizing, susceptible from infected, symptomatic from asymptomatic, essential economic activities from dispensable? cord-286858-zbhtl2yn Or,must we wring the neck of a certain system in order to stuff them into[] pigeon holes for the satisfaction of the analogy mongers 1:"Do the worlds divide neatly into Bruno's three magics- sciences into three disciplines: physics, mathematics, and divine? |
| cord-286858-zbhtl2yn | Turing decidability notion(s) of self(-ves)? |
| cord-286858-zbhtl2yn | Why not use similar features, perhaps, needed in the counter measures to tame it 1?- |
| cord-286858-zbhtl2yn | associated molecular patterns: who signals who? |
| cord-016235-2lhrkmrv | Evolving strategies in lung transplantation for emphysema Surveillance bronchoscopy in lung transplant recipients: risk versus benefit Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection Lung transplantation: a decade of experience Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid Lung transplantation for end- stage pulmonary sarcoidosis: outcome in a series of seven consecutive patients Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation Epstein- Barr virus- negative post- transplant lymphoproliferative disorders: a distinct entity? |
| cord-016235-2lhrkmrv | Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? |
| cord-016235-2lhrkmrv | Prediction of lung- transplant rejection by hepatocyte growth factor Development of malignancy following lung transplantation Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine- based immunosuppression Graft- vs.-host disease in lung and other solid organ transplant recipients Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Lung and Heart/ Lung Transplantation Report-2009 Limitations of spirometry in detecting rejection after singlelung transplantation Surveillance bronchoscopy in children during the first year after lung transplantation: is it worth it? |
| cord-016235-2lhrkmrv | The changing pattern of posttransplant malignancies Does human leukocyte antigen matching influence the outcome of lung transplantation? |
| cord-016235-2lhrkmrv | The effect of recipient's age on lung transplant outcome Pretransplant panel reactive antibody in lung transplant recipients is associated with significantly worse post- transplant survival in a multicenter study Gastroesophageal reflux disease in lung transplant recipients Lung homotransplantation in man Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis Prospective analysis of 1, 235 transbronchial lung biopsies in lung transplant recipients Rejection is reduced in thoracic organ recipients when transplanted in the first year of life C4d deposition in lung allografts is associated with circulating anti- HLA alloantibody Acute and chronic onset of bronchiolitis obliterans syndrome( BOS): are they different entities? |
| cord-016235-2lhrkmrv | The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK Posttransplant lymphoproliferative disorders not associated with Epstein- Barr virus: a distinct entity? |
| cord-016235-2lhrkmrv | The potential role of mast cells in lung allograft rejection Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group Can immunohistological analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts? |
| cord-016235-2lhrkmrv | The role of interleukin-17 during acute rejection after lung transplantation Complications in the native lung after single lung transplantation Obliterative bronchiolitis following lung transplantation: from old to new concepts? |
| cord-023143-fcno330z | *? |
| cord-023143-fcno330z | , Cara Wilsont, Kelledy Mansons, Michael Wyands, Bruce Walker?, Ronald C. Desrosiers |
| cord-023143-fcno330z | However, productive virus replication is minimized by antiviral CD8 T cells which suppress( kill?) |
| cord-023143-fcno330z | PrP genes were used to demonstrate that the"specie9 bank?' |
| cord-023143-fcno330z | The interferons( IFNs) a n? a family of cytokines whose functions include the protection of cells against viral infection. |
| cord-023143-fcno330z | Thes? |
| cord-023143-fcno330z | ofthe influenza HA protein from this second promoter in baby hamster kidney( BHK) cells was approximately 50?? |
| cord-023143-fcno330z | ofthe influenza HA protein from this second promoter in baby hamster kidney( BHK) cells was approximately 50?? |
| cord-004435-l66ost6q | 2020:9 Time for T? |
| cord-004435-l66ost6q | An update and perspective Progress and challenges in TB vaccine development Vaccines for the elderly: current use and future challenges Remembrance of things past: long- term B cell memory after infection and vaccination Global practices of meningococcal vaccine use and impact on invasive disease New vaccine technologies to combat outbreak situations What are the most powerful immunogen design vaccine strategies? |
| cord-004435-l66ost6q | Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges Evaluation of levamisole as an adjuvant for typhoid fever vaccine formulation HLA and infectious diseases Predicting antigen presentation- what could we learn from a million peptides? |
| cord-004435-l66ost6q | How does the VSG coat of bloodstream form African trypanosomes interact with external proteins? |
| cord-004435-l66ost6q | The use of databases, data mining and immunoinformatics in vaccinology: where are we? |
| cord-004435-l66ost6q | Vaccines( Basel) Recalling the future: immunological memory toward unpredictable influenza viruses Human leukocyte antigen( HLA)-binding epitopes dataset for the newly identified T- cell antigens of Mycobacterium immunogenum Fundamentals and methods for T- and B- cell epitope prediction Human Leukocyte Antigen( HLA) and immune regulation: how do classical and non- classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? |
| cord-004435-l66ost6q | and what are the potential clinical implications? |
| cord-004435-l66ost6q | faster de novo structure prediction for linear peptides in solution and in complex The Protein Model Portal- a comprehensive resource for protein structure and model information Exploring Leishmania secretory proteins to design B and T cell multi- epitope subunit vaccine using immunoinformatics approach AP-1 transcription factors as regulators of immune responses in cancer Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? |
| cord-005487-vac061r8 | : do we need a randomized study? |
| cord-005487-vac061r8 | And fi nally, is DCL also observed as a very late complication of hematopoietic stem cell transplantation? |
| cord-005487-vac061r8 | How is the incidence of DCL evolving? |
| cord-005487-vac061r8 | Is development of DCL associated with viral status before and viral reactivation/ infection during as well as after transplantation? |
| cord-005487-vac061r8 | Is the risk of malignant transformation of grafted cells increasing with donor age? |
| cord-005487-vac061r8 | Is there any association with the form and extent of pretreatment( radiotherapy and chemotherapy) implicating a role of damaged microenvironment in the development of DCL? |
| cord-005487-vac061r8 | Is there any infl uence of graft source and donor type( bone marrow vs. peripheral blood stem cells vs. cord blood and related vs. unrelated)? |
| cord-005487-vac061r8 | While convention dictates that MRD is preferred over MUD, does this wisdom hold in RIC SCT? |
| cord-333670-qv1orlv5 | : What Are We Learning in a Country With High Mortality Rate? |
| cord-333670-qv1orlv5 | COVID-19 Pulmonary Involvement: is really an interstitial pneumonia? |
| cord-333670-qv1orlv5 | Could PD-1/ PDL1 immune checkpoints be linked to HLA signature? |
| cord-333670-qv1orlv5 | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-333670-qv1orlv5 | Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-333670-qv1orlv5 | The autopsy debate during the COVID-19 emergency: the Italian experience COVID-19 deaths: are we sure it is pneumonia? |
| cord-333670-qv1orlv5 | The use of antiinflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): the experience of clinical immunologists from China Is COVID evolution due to occurrence of pulmonary vascular thrombosis? |
| cord-028275-szb45jm2 | Describe the significance of animal modeling in biotechnology? |
| cord-028275-szb45jm2 | Discuss about different types of animal model to study the pathogenesis of rheumatoid arthritis? |
| cord-028275-szb45jm2 | Explain the various methods for evaluation of experimental models of Multiple sclerosis? |
| cord-028275-szb45jm2 | Give an example which shows the impact of the epigenetics in the initiation of RA? |
| cord-028275-szb45jm2 | How CIA is induced and how the ability of medications is evaluated in mice? |
| cord-028275-szb45jm2 | The relevance of animal models in multiple sclerosis research Current and emerging treatment of multiple sclerosis HLA and rheumatoid arthritis: how do they connect? |
| cord-028275-szb45jm2 | What is the reason of reportedly experiencing different animal models for studying the pathogenesis of Rheumatoid arthritis? |
| cord-028275-szb45jm2 | Which types of evaluation should be performed after"collagen- induced arthritis"aroused? |
| cord-028275-szb45jm2 | Why the presence of inflammation in the CNS is considered as a hallmark of Multiple Sclerosis? |
| cord-023055-ntbvmssh | -%~~ specific? |
| cord-023055-ntbvmssh | D61 and D62 are 9 and 13 bp long, are frequently recombine as D,1/ D62? and reveal exonucleolytic trimning with extensive"N"segment addition. |
| cord-023055-ntbvmssh | In support of this possibility, thymectomized&+( a x b)F1 chimeras given strain J? marrow cells and a strain thymus graft( irradiated) show no detectable tolerance to host- type strain b determinants: the strain& CD4+ cells differentiating in these chimeras give strong MLR to strain b and do not show deletion of v 11+ cells. |
| cord-023055-ntbvmssh | The efect of these TCR differences on recognition was assessed using a pane? |
| cord-023055-ntbvmssh | The existence of"primed"T cells in phenotypically tolerant animals raises the possibility that precocious activation of TR1( by neonatal exposure to tolerogen?) suppresses the later emergence of T,,, which would be expected to contain the cells responsible for graft rejection. |
| cord-023055-ntbvmssh | The increase peaked at 2 min and returned almost to baseline by 10 mi?. |
| cord-023055-ntbvmssh | Us& this tecfinolosy we have begun to characterize the irmnUne reqonse to individual peptide antigens.? |
| cord-023055-ntbvmssh | Us& this& logy we have begun to characterize the innume response to individual Peptide antigens.? |
| cord-023055-ntbvmssh | We have extended these exper- to inta? |
| cord-023055-ntbvmssh | We reasoned that given the potential for direct peptide/ class?'&$% ation observed in vifro, OVA2s,-2ra may induce CTL after in vivo priming. |
| cord-023055-ntbvmssh | c a l l y autoreactive T cell:? |
| cord-023055-ntbvmssh | e human nutoinimiine tlisrases maintdin:? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare In haploidentical transplants is the incidence of acute and chronic GVHD strictly related to the stem cell source? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare P620 Does body mass index( BMI) pose a risk to outcome for pediatric non- infantile patients undergoing hematopoietic cell transplantation( HSCT)? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare Pre- and- post magnetic resonance imaging of hips and knees for detecting osteonecrosis in children undergoing hematopoietic cell transplantation: In whom is it necessary? |
| cord-005453-4057qib7 | Disclosure: Nothing to disclose Is there any impact of the uric acid levels during the preand early post- graft infusion period, on the GVHD occurence and allotransplant outcome? |
| cord-005453-4057qib7 | Do we need to freeze hematopoietic cells for autotransplants in patients with myeloma conditioned with melphalan? |
| cord-005453-4057qib7 | Is fungal prophylaxis necessary in non myeloablative peripheral blood stem cell allogeneic transplantation in the pre- engrafment period? |
| cord-005453-4057qib7 | Is it really GVHD? |
| cord-005453-4057qib7 | Nothing to declare Is mobilization with chemotherapy effect response in the multiple myeloma? |
| cord-005453-4057qib7 | Nothing to declare Is there any association between thrombotic risk factors and veno- oclusive disease in childhood allogeneic hematopoietic stem cell transplantation? |
| cord-010088-s9tfvtao | 3C- S14- 01 DO WE REALLY NEED FFP? |
| cord-010088-s9tfvtao | But is this a myth? |
| cord-010088-s9tfvtao | But was the three- gene theory really wrong, when the boundaries of genes were not understood at the time? |
| cord-010088-s9tfvtao | But who decides what is false? |
| cord-010088-s9tfvtao | How can they be investigated and what should be considered? |
| cord-010088-s9tfvtao | How do I know if I have enough information to write a paper? |
| cord-010088-s9tfvtao | How has this happened? |
| cord-010088-s9tfvtao | How should my paper be put together to give it the best chance of being accepted? |
| cord-010088-s9tfvtao | If it is returned to me with comments from the reviewers, what should I do? |
| cord-010088-s9tfvtao | Is it an ATMP or non- manipulated cell product, is it a blood product or a pharmaceutical? |
| cord-010088-s9tfvtao | NEXT? |
| cord-010088-s9tfvtao | WHATS NEW WITH TRALI? |
| cord-010088-s9tfvtao | What happens to my paper after I submit it? |
| cord-010088-s9tfvtao | What is my next step if my paper is rejected, either without review or with review? |
| cord-010088-s9tfvtao | What is the value of discussing case studies? |
| cord-010088-s9tfvtao | What should be considered in different clinical situations? |
| cord-010088-s9tfvtao | Where should I try to publish the paper? |
| cord-010119-t1x9gknd | Among all potential causes investigated, only the gel card lot number was associated with the number of"?"generated( table 1). |
| cord-010119-t1x9gknd | Assuming 30 seconds of technologist time per"?", we estimate that 13.6 hours were needed to resolve and update these results. |
| cord-010119-t1x9gknd | Can Texting Decrease Wastage? |
| cord-010119-t1x9gknd | Interference: More Than Just Kell? |
| cord-010119-t1x9gknd | Is Its Use Inappropriate? |
| cord-010119-t1x9gknd | Of 19,647 columns run as part of antibody screens, 1,633( 8.3%) columns generated"? |
| cord-010119-t1x9gknd | Patient 1 was a 29 yo female, C2E2c1e1, whose RBCs reacted 11 by ECHO and 31 by NEO with anti- D4, and'?' |
| cord-010119-t1x9gknd | Platelet Rich Plasma and Quality Control: Is There a Role for the Blood Bank? |
| cord-010119-t1x9gknd | Shortly after implementation, technologists reported increased time spent performing manual resolution of indeterminate( designated as"?") results. |
| cord-010119-t1x9gknd | Study Design/ Method: We analyzed allogeneic interview responses to the screening question,"In the past 12 months have you had a tattoo?" |
| cord-010119-t1x9gknd | Study Design/ Methods: With assistance from Ortho Diagnostics, analyzer archives were queried to identify the number of gel card columns used for screens, the number of columns with"?"results, and the gel card lot numbers used for testing from 1/29/2017 to 3/31/2017. |
| cord-010119-t1x9gknd | Testing Worth the Headache? |
| cord-010119-t1x9gknd | Texas Children's Hospital, 2 Baylor College of Medicine AP127 Vision Titers--Easier or Problematic? |
| cord-010119-t1x9gknd | The Future of Plasma Therapy? |
| cord-010119-t1x9gknd | The incidence of"?"and visually negative analyzer positive results is dependent on the specific lot of MTS- Gel TM cards used. |
| cord-010119-t1x9gknd | The objective of this study was to investigate the cause of"?"and apparent false positive results on VisionV R three- cell antibody screens. |
| cord-010119-t1x9gknd | Variations in Biochemical Markers of Bone Metabolism during Plateletpheresis: Impact of Socio- Demographic and Lifestyle Factors? |
| cord-010119-t1x9gknd | Were Patients Transfused after Testing? |
| cord-010119-t1x9gknd | What Is the Best Practice for Testing Residual White Blood Cells in Blood Components for Monthly Routine Quality Control? |
| cord-010119-t1x9gknd | Where We Go? |
| cord-010092-uftc8inx | Can you confirm my genotype? cord-010092-uftc8inx Who is a blood donor recruiter?"was the topic of ABD- VII at 9- 11 March 2018. |
| cord-010092-uftc8inx | 4A- S18- 05 WHO IS SYPHILIS TESTING EXCLUDING? |
| cord-010092-uftc8inx | : IS IT TIME TO LABEL EACH UNIT WITH HB CONTENT? |
| cord-010092-uftc8inx | A donor was classified as"tired"if they responded"all the time"or"most of the time"to the question"how often do you feel that you lacked energy and strength?". |
| cord-010092-uftc8inx | ALL TOGETHER? |
| cord-010092-uftc8inx | Are we alone in the Universe? |
| cord-010092-uftc8inx | As a consequence, questions asked 30 years ago have changed: Today, molecular biologists looking at hundreds of newly discovered blood group alleles find themselves not being asked by serologists any more:"Can you confirm my serology?", but instead, pose their question to the experts for the blood group phenotype: |
| cord-010092-uftc8inx | But can we apply the metaphor as successfully into donating blood for research? |
| cord-010092-uftc8inx | Donors and Donation-Donor Adherence-are we doing the Right Thing? |
| cord-010092-uftc8inx | How can we start using this tool in unison with our existing tools to improve science and clinical practice in our respective( bio)medical fields? |
| cord-010092-uftc8inx | So is there a future for new anti- platelet agents? |
| cord-010092-uftc8inx | To evaluate self- rated health we used the well- validated single question:"How would you rate your health in general?". |
| cord-010092-uftc8inx | WHAT CAN WE LEARN FROM HOW ADVERSE EVENTS ARE DETECTED? |
| cord-010092-uftc8inx | What is the optimal balance between iron supplementation and prolongation of interdonation intervals? |
| cord-010092-uftc8inx | What then is the best approach to use? |
| cord-010092-uftc8inx | Where are we from? |
| cord-010092-uftc8inx | Where are we going? |
| cord-010092-uftc8inx | Will serologic typing be replaced by DNAbased typing? |
| cord-010092-uftc8inx | but how does this affect health? |
| cord-023346-8sqbqjm1 | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023346-8sqbqjm1 | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023346-8sqbqjm1 | : will it become reality? |
| cord-023346-8sqbqjm1 | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023346-8sqbqjm1 | Against this background where should our attentions focus? |
| cord-023346-8sqbqjm1 | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023346-8sqbqjm1 | An ISO standard for blood transfusion? |
| cord-023346-8sqbqjm1 | Are transfusion guidelines evidence- based? |
| cord-023346-8sqbqjm1 | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023346-8sqbqjm1 | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023346-8sqbqjm1 | Is it a mutual decision making between physician and patient? |
| cord-023346-8sqbqjm1 | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023346-8sqbqjm1 | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023346-8sqbqjm1 | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023346-8sqbqjm1 | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023346-8sqbqjm1 | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023346-8sqbqjm1 | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023346-8sqbqjm1 | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023346-8sqbqjm1 | What is however the meaning of informed consent? |
| cord-023346-8sqbqjm1 | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023346-8sqbqjm1 | Who will hear it? |
| cord-023346-8sqbqjm1 | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023346-8sqbqjm1 | to apply which screening method? |
| cord-023346-8sqbqjm1 | your Trima ® can be? |
| cord-023354-f2ciho6o | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023354-f2ciho6o | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023354-f2ciho6o | : will it become reality? |
| cord-023354-f2ciho6o | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023354-f2ciho6o | Against this background where should our attentions focus? |
| cord-023354-f2ciho6o | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023354-f2ciho6o | An ISO standard for blood transfusion? |
| cord-023354-f2ciho6o | Are transfusion guidelines evidence- based? |
| cord-023354-f2ciho6o | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023354-f2ciho6o | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023354-f2ciho6o | Is it a mutual decision making between physician and patient? |
| cord-023354-f2ciho6o | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023354-f2ciho6o | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023354-f2ciho6o | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023354-f2ciho6o | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023354-f2ciho6o | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023354-f2ciho6o | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023354-f2ciho6o | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023354-f2ciho6o | What is however the meaning of informed consent? |
| cord-023354-f2ciho6o | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023354-f2ciho6o | Who will hear it? |
| cord-023354-f2ciho6o | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023354-f2ciho6o | to apply which screening method? |
| cord-023354-f2ciho6o | your Trima ® can be? |
| cord-023364-ut56gczm | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023364-ut56gczm | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023364-ut56gczm | : will it become reality? |
| cord-023364-ut56gczm | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023364-ut56gczm | Against this background where should our attentions focus? |
| cord-023364-ut56gczm | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023364-ut56gczm | An ISO standard for blood transfusion? |
| cord-023364-ut56gczm | Are transfusion guidelines evidence- based? |
| cord-023364-ut56gczm | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023364-ut56gczm | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023364-ut56gczm | Is it a mutual decision making between physician and patient? |
| cord-023364-ut56gczm | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023364-ut56gczm | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023364-ut56gczm | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023364-ut56gczm | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023364-ut56gczm | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023364-ut56gczm | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023364-ut56gczm | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023364-ut56gczm | What is however the meaning of informed consent? |
| cord-023364-ut56gczm | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023364-ut56gczm | Who will hear it? |
| cord-023364-ut56gczm | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023364-ut56gczm | to apply which screening method? |
| cord-023364-ut56gczm | your Trima ® can be? |